Oncotarget:Dedicated To Sharing Accurate Important Research Results

Since 2010, Impact Journals has been publishing an open access weekly peer-reviewed medical journal called Oncotarget. The publication provides the latest research information dealing with all aspects of oncology. The articles and papers that appear in Oncotarget are written by some of the leading figures in cancer research. Roswell Park Cancer Institute researchers and instructors Andrei Gudkov and Mikhail Blagosklonny… More →

“Cancer Treatment Centers of America – Changing the Future of Medical Care”

Cancer Treatment Centers of America has joined forces with NantHealth and Allscripts to offer oncologists the most current results for various cancer treatments. Eviti® is NantHealth’s Software as a Service, (SaaS) platform to allow physicians access to electronic health records (EHR), in which they are able to search for the proper solution for their patients. With Eviti® in place, oncologist… More →

Oncotarget, a Medical Journal Dealing With Oncology

Individuals are encouraged to read these articles more so because the journal is free. This means that it can be easily accessible. Publication is on a weekly basis so individuals can look forward to different topics every now and then. Visit: http://www.bioxbio.com/if/html/ONCOTARGET.html The world of medicine is often considered complex. There are various diseases with difficult names as well as… More →

The Excellent Contributions of Amicus Therapeutics to the Pharmaceuticals Industry

Amicus Therapeutics Inc. is an internationally recognized biotechnology firm that has specialized in developing advanced therapies that can be used in curing a variety of life-threatening rare and orphan diseases. The company has currently developed several treatments for different human genetic diseases. Amicus’ main offices are located in Cranbury, New Hersey, The firm has been publicly traded since 2007, and… More →

Leading New Brunswick Developer Joins Elite in Genomics Research

For his contribution to the groundbreaking research conducted at Rutgers Cancer Institute of New Jersey, leading New Brunswick developer Omar Boraie has been acknowledged with the Omar Boraie Chair in Genomic Science. The “18 Chairs” According to a story published by NewsWise, this accolade is considered a higher education gold standard and the tribute illustrates commitment to an academic discipline,… More →